REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s

We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last month the RECOVERY trial has released the result that monoclonal REGN antibodies are effective for a subgroup of hospitalised patients with COVID-19 . We await … Continue reading REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s